Literature DB >> 9864229

Vibrio anguillarum resistance to rainbow trout (Oncorhynchus mykiss) serum: role of O-antigen structure of lipopolysaccharide.

H T Boesen1, K Pedersen, J L Larsen, C Koch, A E Ellis.   

Abstract

The sensitivity of Vibrio anguillarum to the bactericidal effect of rainbow trout serum was investigated with different strains of serogroups O1 and O2a, which are the most frequently found serogroups in clinical outbreaks of vibriosis. All of the V. anguillarum strains were able to activate complement in rainbow trout serum, but smooth strains of V. anguillarum serogroup O1 were resistant to complement-mediated killing in the absence of specific antibodies. In the case of V. anguillarum serogroup O2a strains, 80% of the analyzed strains were resistant to rainbow trout serum even when specific antibodies were present. Analysis of the lipopolysaccharide structures of the tested V. anguillarum strains showed a positive correlation between the O-antigen size of the lipopolysaccharide and resistance to serum killing. The classical complement pathway was responsible for the antibody-dependent serum killing of susceptible V. anguillarum strains. When serum-resistant V. anguillarum serogroup O2a strains were grown in glucose-enriched Lennox L broth, they produced lipopolysaccharide molecules with fewer high-molecular-weight O-antigen units than did strains grown in broth without the addition of glucose. Strains grown in glucose-enriched medium became sensitive to rainbow trout serum killing, indicating that the high-molecular-weight O-antigen side chains prevented the activated complement from damaging the bacterium.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9864229      PMCID: PMC96310     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing.

Authors:  S Merino; S Camprubí; S Albertí; V J Benedí; J M Tomás
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  A STUDY OF THE RELATIONSHIP OF THE NORMAL BACTERICIDAL ACTIVITY OF HUMAN SERUM TO BACTERIAL INFECTION.

Authors:  R J Roantree; L A Rantz
Journal:  J Clin Invest       Date:  1960-01       Impact factor: 14.808

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Functional role of antibody against "core" glycolipid of Enterobacteriaceae.

Authors:  L S Young; P Stevens; J Ingram
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

5.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS).

Authors:  D C Morrison; L F Kline
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  Molecular factors associated with virulence of marine vibrios isolated from striped bass in Chesapeake Bay.

Authors:  A E Toranzo; J L Barja; S A Potter; R R Colwell; F M Hetrick; J H Crosa
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

7.  Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity.

Authors:  J M Tomás; V J Benedí; B Ciurana; J Jofre
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

8.  Comparative Serology of the Marine Fish Pathogen Vibrio anguillarum.

Authors:  L Grisez; F Ollevier
Journal:  Appl Environ Microbiol       Date:  1995-12       Impact factor: 4.792

9.  The role of lipopolysaccharide in complement-killing of Aeromonas hydrophila strains of serotype O:34.

Authors:  S Merino; S Camprubí; J M Tomás
Journal:  J Gen Microbiol       Date:  1991-07

10.  Role of lipopolysaccharide and complement in susceptibility of Haemophilus ducreyi to human serum.

Authors:  J A Odumeru; G M Wiseman; A R Ronald
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

View more
  8 in total

1.  Novel role of the lipopolysaccharide O1 side chain in ferric siderophore transport and virulence of Vibrio anguillarum.

Authors:  Timothy J Welch; Jorge H Crosa
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Two cathelicidin genes are present in both rainbow trout (Oncorhynchus mykiss) and atlantic salmon (Salmo salar).

Authors:  Chin-I Chang; Yong-An Zhang; Jun Zou; Pin Nie; Christopher J Secombes
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

3.  Characterization and pathogenicity of the zinc metalloprotease empA of Vibrio anguillarum expressed in Escherichia coli.

Authors:  Hui Yang; Jixiang Chen; Guanpin Yang; Xiao-Hua Zhang; Yun Li; Min Wang
Journal:  Curr Microbiol       Date:  2007-03       Impact factor: 2.188

4.  Lipopolysaccharide O-antigen prevents phagocytosis of Vibrio anguillarum by rainbow trout (Oncorhynchus mykiss) skin epithelial cells.

Authors:  Kristoffer Lindell; Anna Fahlgren; Erik Hjerde; Nils-Peder Willassen; Maria Fällman; Debra L Milton
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

Review 5.  Maintenance of Fish Health in Aquaculture: Review of Epidemiological Approaches for Prevention and Control of Infectious Disease of Fish.

Authors:  Ayalew Assefa; Fufa Abunna
Journal:  Vet Med Int       Date:  2018-02-26

6.  The Expression of Virulence Factors in Vibrio anguillarum Is Dually Regulated by Iron Levels and Temperature.

Authors:  Marta A Lages; Miguel Balado; Manuel L Lemos
Journal:  Front Microbiol       Date:  2019-10-15       Impact factor: 5.640

7.  Fructose Promotes Crucian Carp Survival Against Aeromonas hydrophila Infection.

Authors:  Yunchao Cao; Tianshun Kou; Liaotian Peng; Hetron Mweemba Munang'andu; Bo Peng
Journal:  Front Immunol       Date:  2022-03-21       Impact factor: 7.561

8.  Does virulence assessment of Vibrio anguillarum using sea bass (Dicentrarchus labrax) larvae correspond with genotypic and phenotypic characterization?

Authors:  Ingeborg Frans; Kristof Dierckens; Sam Crauwels; Ado Van Assche; Jørgen J Leisner; Jørgen Leisner; Marianne H Larsen; Chris W Michiels; Kris A Willems; Bart Lievens; Peter Bossier; Hans Rediers
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.